APA (7th ed.) Citation

C, V., R, A., M, L., P, H., R, D. A. L., & S, G. (2024). Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy. Applied health economics and health policy, 22(1), 73. https://doi.org/10.1007/s40258-023-00853-1

Chicago Style (17th ed.) Citation

C, Vargas, Addo R, Lewandowska M, Haywood P, De Abreu Lourenco R, and Goodall S. "Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy." Applied Health Economics and Health Policy 22, no. 1 (2024): 73. https://doi.org/10.1007/s40258-023-00853-1.

MLA (9th ed.) Citation

C, Vargas, et al. "Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy." Applied Health Economics and Health Policy, vol. 22, no. 1, 2024, p. 73, https://doi.org/10.1007/s40258-023-00853-1.